022 24172311
Sections
Search
DealCurry
Equity
Venture Capital
Private Equity
M&A

Mergers & Acquisitions | 28 April 2011

Biocon To Sell Its 78% Stake In AxiCorp For $58 Mn

by Deeshesh Chheda
Biocon To Sell Its 78% Stake In AxiCorp For $58 Mn
Share on Social Media Email Facebook Twitter Linkedin
 
@deeshesh

Biocon Ltd will be selling its entire 78% stake in it's German unit, AxiCorp GmbH, to minority shareholders, for 40 million euros ($58.2 Mn).

AxiCorp was the licensee for Biocon's insulin and Glargine products in Germany and had the sole responsibility for commercialising these products.

Transactio Reference: Business Standard


{TAG_10522_1303984599}

Religare To Raise Rs 800 Cr Via Rights Issue

Religare To Raise Rs 800 Cr Via Rights Issue

Religare Enterprises Limited will raise Rs.800 Cr through rights issue, with an option to increase the issue size by additional 10%.

Read More...

Warburg Pincus, General Atlantic To Acquire Majority Stake In Sharekhan

Warburg Pincus, General Atlantic To Acquire Majority Stake In Sharekhan

After five months of negotiations and competitive bidding, the global PE funds Warburg Pincus and General Atlantic, emerge as the frontrunner to buy a majority stake in brokerage and financial services firm, Sharekhan at a deal valued between R2,000- 2,400 Cr.

Read More...
Subscribe
Enter your Email address
to receive all the news